loading...| Preferred Name |
Silybin |
|
| Synonyms |
Cefasilymarin |
|
| Definitions |
The major active component of silymarin flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum; it is used in the treatment of HEPATITIS; LIVER CIRRHOSIS; and CHEMICAL AND DRUG INDUCED LIVER INJURY, and has antineoplastic activity; silybins A and B are diastereomers. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000077385 |
|
| altLabel |
Cefasilymarin HepaBesch Ardeyhepan Hepa Merz Sil Hepa loges Hepar Pasc Silibinin B Hepa-loges Silybin A Hepa-Merz Sil Heparsyx Hepar-Pasc Silybin B 2,3 Dehydrosilybin Legalon Forte Alepa-forte 2,3-Dehydrosilybin Alepa forte Heplant Lagosa Silibinin A Silibinin Silibin Silybinin Durasilymarin 4H-1-Benzopyran-4-one, 2-((2R,3R)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)- |
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR |
|
| cui |
C1528831 C0600334 C1742989 C1528834 C1528833 C1528826 C4508862 C4508861 C1528837 C1528832 C1528829 C1528836 C1528827 C1528830 C2975124 C1528828 |
|
| DC |
1 |
|
| definition |
The major active component of silymarin flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum; it is used in the treatment of HEPATITIS; LIVER CIRRHOSIS; and CHEMICAL AND DRUG INDUCED LIVER INJURY, and has antineoplastic activity; silybins A and B are diastereomers. |
|
| DX |
20190101 |
|
| HN |
2019 (2002) |
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
33X338MNE4 853OHH1429 4RKY41TBTF 0 |
|
| isa | ||
| LT |
TRD |
|
| Machine permutation |
2019; SILYBIN was indexed under SILYMARIN 2002-2018 |
|
| Mapped from |
http://purl.bioontology.org/ontology/MESH/C087301 http://purl.bioontology.org/ontology/MESH/C472368 |
|
| MDA |
20180709 |
|
| MMR |
20180507 |
|
| MN |
D03.383.663.283.266.450.268.777.500 D03.633.100.150.266.450.268.777.500 |
|
| notation |
D000077385 |
|
| PA |
D000972 D020011 |
|
| prefLabel |
Silybin |
|
| RR |
33X338MNE4 853OHH1429 22888-70-6 (Silybin) |
|
| TERMUI |
T000939561 T000939557 T000939555 T618407 T000939553 T000939554 T618417 T000939560 T618415 T000939558 T618405 T000939556 T618403 T000939564 T618413 T000939562 T000939559 T618425 T618419 T000939563 T618423 |
|
| TH |
FDA SRS (2018) NLM (1990) FDA SRS (2013) NLM (2019) NLM (1985) INN (19XX) NLM (2006) DE NLM (2017) NLM (2007) NLM (1974) |
|
| tui |
T109 T121 |
|
| subClassOf |